The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Good Afternoon and welcome to HotCopper Highlights for the end of Week 19, I’m Jon Davidson. In this segment we go through the stocks that you were watching and discussing most – let’s get into it.

Starting with the most viewed, 

WebJet Group caught eyes late week after its share price popped nearly 20% on Monday on no news, climbing to 80cps. While it looked like oil prices or even the Fed could have charged sentiment, WebJet revealed on Friday an undisclosed buyer is amassing 5% of the company. Shares were trading at 83 cents intraday.  

Elsewhere, Chrysos Corporation was the top gainer on Friday as gold giant Newmont Corporation moved in to pick up the company’s X-ray based gold assay tech. Chrysos didn’t cite a value on the contract – but there will be an undisclosed fee per sample when Newmont start assaying in Ghana. Shares traded at $4.90 each intraday. 

And so what about the most discussed? 

Toll road heavyweight Transurban this week confirmed it’s going to slash up to 300 jobs. The news was taken well by investors, but didn’t reflect any dramatic surge in share price. Profit takers moved in on Friday, pushing shares down -1.8% to $14.25 per share intraday on Friday.

Earlier in the week, health insurance giant Medibank gave its view on what Trump’s tariff regime means for the stock, with a relatively insulated Australian operations base grazed by some investments Medibank made into Wall Street. The company said between the lines, in the worst case trade war scenario, it could lose $240M worth of capital. While shares were down -1% to $4.70 on Friday, one week performance was just shy of a percent – suggesting the market wasn’t too bothered by that news.

That’s HotCopper Highlights, I’m Jonathon Davidson, have a great weekend and we’ll see you on Monday. 

More From The Market Online

KGL Resources jumps 25% on US$300M funding deal

KGL Resources has entered into a US$300 million PMPA to help fund construction and development of…
London

With osteo Phase 3 trial at 50% recruitment, Paradigm Bio inks partnership with University of London

Paradigm Biopharma (ASX:PAR) has this week hit two big items out the park: first of all, hitting 50% recruitment

Terra hits multiple intersections at Southwest SW6 prospect; assays now due in next ~12 weeks

Terra Metals has hit multiple intersections of massive sulphides in drilling at the Southwest SW6 prospect…
Easter bunny in a business suit analyzing stock charts, symbolizing market strategy

ASX closed for Easter long weekend. Enjoy your chocolates and the holiday break!

Yes, yes, I know you’re itching to do some serious Australian market trading today, but everyone — especially our much-loved HotCopper forum users